Production of surfactin from Bacillus subtilis MZ-7 grown on pharmamedia commercial medium

65Citations
Citations of this article
161Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Commercial medium (Pharmamedia) was investigated for the production of surfactin by Bacillus subtilis MZ-7. Different media (defined, semi-defined, and complex media) were compared for the production of surfactin after fixing the least influential variables in standardized fermentation conditions. Carbohydrate and nitrogen supplements were also tried to improve production in Pharmamedia. Results: Surfactin production was confirmed using PCR along with other analytical techniques and monitored by RP-HPLC and MALDI-TOF-MS. We found that optimized and brain heart infusion media were best for production of surfactin (280 mg/L) and a relatively comparable production with Pharmamedia (220 mg/L), however, supplementing Pharmamedia with Fe+ (4.0 mM) and sucrose (2 g/L) leads to a maximum production of about (300 mg/L). Conclusion: Cottonseed-derived medium proved to be a suitable substrate for the production of bioactive substances including surfactin, a useful compound in both medical and biotechnological fields. The medium provided not only higher product accumulations but at considerably lower cost with potential for large scale industrial applications. © 2007 Al-Ajlani et al; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Al-Ajlani, M. M., Sheikh, M. A., Ahmad, Z., & Hasnain, S. (2007). Production of surfactin from Bacillus subtilis MZ-7 grown on pharmamedia commercial medium. Microbial Cell Factories, 6. https://doi.org/10.1186/1475-2859-6-17

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free